Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02397811 · ClinicalTrials.gov registry record · NA
Astaxanthin Formulation Bioavailability
A NA study of Bioavailability of Astaxanthin Formulations, sponsored by Cyanotech Corporation.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02397811 is a NA study of Bioavailability of Astaxanthin Formulations that has completed, run by Cyanotech Corporation. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02397811, a NA study of Bioavailability of Astaxanthin Formulations, has completed, sponsored by Cyanotech Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Human crossover pharmacokinetic study involving 12 subjects to determine the relative bioavailability of astaxanthin in six commercially available oral formulations.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Enteric Coated Softgels
- DIETARY_SUPPLEMENT Liposomal astaxanthin
- DIETARY_SUPPLEMENT Standard Softgel
- DIETARY_SUPPLEMENT Astaxanthin Water Soluble Emulsion
- DIETARY_SUPPLEMENT Astaxanthin Water Dispersible Powder
Study Locations (1)
Florida
- USF Health: College of Medicine - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-06 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02397811
The ClinicalTrials.gov registry entry for NCT02397811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyanotech Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bioavailability of Astaxanthin Formulations appearing as the primary indexed condition, and to 5 interventions - of which Enteric Coated Softgels is the first listed.
NCT02397811 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02397811 about?
NCT02397811 is a clinical study titled "Astaxanthin Formulation Bioavailability". Human crossover pharmacokinetic study involving 12 subjects to determine the relative bioavailability of astaxanthin in six commercially available oral formulations.
What is the current status of trial NCT02397811?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-06. Estimated completion is 2015-12.
What conditions does trial NCT02397811 study?
This clinical trial studies the following conditions: Bioavailability of Astaxanthin Formulations.
What interventions are being tested in trial NCT02397811?
The interventions under investigation include: Enteric Coated Softgels (DIETARY_SUPPLEMENT), Liposomal astaxanthin (DIETARY_SUPPLEMENT), Standard Softgel (DIETARY_SUPPLEMENT), Astaxanthin Water Soluble Emulsion (DIETARY_SUPPLEMENT), Astaxanthin Water Dispersible Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02397811?
This trial is sponsored by Cyanotech Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02397811 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.